OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
OSR Holdings (NASDAQ:OSRH) will present its VXM01 global licensing agreement at the Emerging Growth Conference on May 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OSR Holdings (NASDAQ:OSRH) will present its VXM01 global licensing agreement at the Emerging Growth Conference on May 7, 2026. The virtual presentation is scheduled for 4:10 p.m. ET and will include an overview and a live Q&A.
Tim Smith, Head of Investor Relations, will discuss the recently executed licensing agreement and answer investor questions. Registration is required for live attendance; an archived webcast will be available on EmergingGrowth.com, the Emerging Growth YouTube channel, and the company's Events & Presentations page.
Details
News Market Reaction – OSRH
On Apr 30, the day this news came out, OSRH closed 52.80% above the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Conference date
- May 7, 2026
- Emerging Growth Conference VXM01 licensing presentation
- Presentation time
- 4:10 p.m. ET
- Scheduled start of VXM01 licensing overview and Q&A
Historical Context
-
Signed $815M VXM01 global license with BCM Europe and related share pledges.
-
Convertible note transaction to retire $2.02M in warrants and cut dilution risk.
-
Planned Emerging Growth Conference update on VXM01 and Woori IO platform.
-
Flash report reaffirmed Buy-Emerging rating and $10.00 target with VXM01 focus.
-
Revised VXM01 deal to route up to $815M milestones directly to OSR Holdings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
BELLEVUE, WA / ACCESS Newswire / April 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. The presentation will provide investors and analysts with an overview of the Company's landmark VXM01 global licensing agreement and its implications for OSRH shareholders.
Virtual Presentation Details
Date: May 7, 2026
Time: 4:10 p.m. ET
Format: VXM01 Licensing Overview and Q&A
Registration: https://goto.webcasts.com/starthere.jsp?ei=1755070&tp_key=280dc3ffe3&sti=oshr
Tim Smith, Head of Investor Relations, will give an in-depth view of the recently executed VXM01 global licensing agreement, followed by a Q&A session. Investors are encouraged to submit questions in advance to Questions@EmergingGrowth.com or during the live event and management will address as many questions as possible.
Attendees are encouraged to register in advance. For those unable to attend live, an archived webcast will be available at EmergingGrowth.com, the Emerging Growth YouTube Channel, and in the "Events & Presentations" section of the Company's website OSR-Holdings.com.
To view the Company's previous presentation, visit:
https://www.youtube.com/watch?v=n7CjcvlFVzw&t=377s
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.
All sessions will be conducted through video webcasts and will take place in the Eastern time zone.
About OSR Holdings
OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSRH engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.OSR-Holdings.com.
Investor Contact
OSR Holdings, Inc.
Investor Relations
ir@osr-holdings.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable U.S. securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements, except as required by law.
SOURCE: OSR Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.